- Global Pharma News & Resources

Rani Therapeutics' CEO Mir Imran Selected for the 2018 Upstart 50 List

Rani Therapeutics' CEO Mir Imran Selected for the 2018 Upstart 50 List Annual program honors investors, creatives, backers and masters who represent the most dynamic, disruptive and innovative people doing business in the San Francisco Bay Area

PR Newswire

SAN JOSE, Calif., Sept. 7, 2018

SAN JOSE, Calif., Sept. 7, 2018 /PRNewswire/ -- Rani Therapeutics, a pioneer in oral biologics, today announced that Chairman and CEO Mir Imran was chosen for the 2018 Upstart 50 list. Selected by the editors at the San Francisco Business Times and the Silicon Valley Business Journal, the Upstart 50 is an annual recognition of the most dynamic, disruptive and innovative people doing business today in the San Francisco Bay Area.

As part of the 2018 class, Imran joins a distinguished and diverse group of startup founders, venture capitalists, creative minds and influencers who have made an impact on business. Previous honorees include Sequoia Capital Partner Jess Lee, One Medical founder Tom Lee and technology pioneers Mitch and Freada Kapor. At the Upstart 50 cocktail event last night, Imran was interviewed in a fireside chat, where he shared his best stories and lessons as a prolific inventor, investor and serial entrepreneur.

Imran has spent nearly 40 years creating and commercializing breakthrough medical innovations. His most recent invention, the RaniPillâ„¢ capsule, has the potential to disrupt the pharmaceutical industry by converting injectable medications into pills.

"Understanding and trying to solve big problems continues to motivate me every day," said Mir Imran, Chairman and CEO of Rani Therapeutics. "Most recently with Rani, we have taken a completely unique approach to a decades-old challenge that affects millions of patients every day. It's very gratifying to be honored for this work, but the real reward will be when we can dramatically improve the lives of millions of people around the world."

The full list of recipients can be found at:

About Rani Therapeutics
Rani Therapeutics has developed a novel approach for the oral delivery of large drug molecules including peptides, proteins and antibodies, which to date can only be delivered through injections. The approach and technology for Rani Therapeutics was developed at InCube Labs, a multi-disciplinary life sciences R&D lab focused on developing breakthrough medical innovations. InCube is led by Mir Imran, a prolific medical inventor, entrepreneur and investor. Mir has founded more than 20 life sciences companies and is an inventor on more than 400 issued and pending patents in the U.S and foreign jurisdictions. For more information, please visit: and

Media Contact:
Cathy Summers
Consort Partners for Rani Therapeutics


View original content:

SOURCE Rani Therapeutics

Editor Details

Last Updated: 07-Sep-2018